ProShare Advisors’s Clover Health Investments CLOV Stock Holding History

ProShare Advisors’s Portfolio CLOV Stock Details CLOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$289K	Sell	55,079 -4,168	-7%	-$14.2K	﹤0.01%	1438
2026 Q1	$104K	Sell	59,247 -15,453	-21%	-$33.5K	﹤0.01%	1700
2025 Q4	$176K	Buy	74,700 +5,660	+8%	+$15.5K	﹤0.01%	1760
2025 Q3	$211K	Sell	69,040 -13,756	-17%	-$39.3K	﹤0.01%	1669
2025 Q2	$231K	Buy	+82,796	New	+$272K	﹤0.01%	1630
2023 Q2	–	Sell	-45,468	Closed	-$38.4K	–	1859
2023 Q1	$38.4K	Sell	45,468 -4,240	-9%	-$4.64K	﹤0.01%	1697
2022 Q4	$46.2K	Buy	49,708 +7,124	+17%	+$9.51K	﹤0.01%	1744
2022 Q3	$73K	Sell	42,584 -280	-0.7%	-$733	﹤0.01%	1611
2022 Q2	$91K	Buy	+42,864	New	+$114K	﹤0.01%	1626

Other funds holding CLOV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

ProShare Advisors's CLOV Position: Q2 2026 in Review

ProShare Advisors reduced its Clover Health Investments (CLOV) stake by 7% in Q2 2026, selling an estimated $14.2K and leaving 55,079 shares worth $289K. The position accounts for ﹤0.01% of the portfolio, ranked #1438.

ProShare Advisors first reported a position in CLOV in Q2 2022 and has held it in 9 quarters since. 226 funds tracked by Wall St. Rank hold CLOV as of Q2 2026.

ProShare Advisors held 55,079 shares of Clover Health Investments worth $289K as of Q2 2026.
ProShare Advisors sold 4,168 Clover Health Investments shares in Q2 2026, an estimated $14.2K.
Clover Health Investments made up ﹤0.01% of ProShare Advisors's portfolio in Q2 2026, its #1438 holding.
ProShare Advisors first reported a position in Clover Health Investments in Q2 2022 and has held it in 9 quarters since.
226 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2026.

Based on ProShare Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.